Mapha Medical (301033.SZ): Absorbable regenerated oxidized cellulose hemostatic granules enter the clinical trial stage.

Zh tng cijng APP xn, mi p yxu (301033.SZ) gnggo, gngs ynf xingm "k xshu zishng ynghu xn wis zh xu kl" y jnq zhngsh jnr lnchng shyn jidun. Zi wik shush zhng, dng jizu hu qt chuntng de zh xu fngf wf cozu hu wxio sh, gi chnpn k zuwi fzh zh xu chnpn yngy kngzh mo x xugun, jngmi j xio dngmi de sxu. The Zhtng Finance APP reports that Maple Medical (301033.SZ) announced that the company's research and development project "absorbable regenerated oxidized cellulose hemostatic particles" has officially entered the clinical trial stage recently. In surgical procedures, when ligation or other traditional hemostasis methods are not feasible or effective, the product can be used as an auxiliary hemostatic product to control oozing of capillaries, veins, and small arteries.